Market Overview

Akorn Shares Rally Following Increased Price Target

Related AKRX
Does Reward Potential Still Outweigh The Risk In Akorn Shares?
15 Biggest Mid-Day Losers For Monday
The Vetr community has downgraded $AKRX to 3.5-Stars (Vetr)

Shares of Akorn (NASDAQ: AKRX) were up nearly 10 percent Tuesday around $36.50 following the release of a Needham note in which the price target for the company was raised from $30 to $40.

The note cited a "game changing" effect if Akorn matches Taro Pharmaceutical Industries' recent price increases in topical generics.

Shares are currently up 5.25 percent at $34.99.

Latest Ratings for AKRX

Mar 2017Deutsche BankDowngradesBuyHold
Dec 2016Goldman SachsInitiates Coverage OnSell
Nov 2016Bank of AmericaDowngradesBuyUnderperform

View More Analyst Ratings for AKRX
View the Latest Analyst Ratings

Posted-In: NeedhamAnalyst Color News Price Target Analyst Ratings


Related Articles (AKRX)

View Comments and Join the Discussion!